Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Surface Oncology, Inc.
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
August 31, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
CHRS
SURF
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
August 02, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Coherus to Acquire Surface Oncology
June 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
CHRS
SURF
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
May 04, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
April 18, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023
March 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
March 09, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference
February 02, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors
January 05, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology to Present Non-clinical Data for SRF388 and SRF114 at the Society for Immunotherapy of Cancer 2022 Annual Meeting
November 07, 2022
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Surface Oncology Announces Promising SRF388 Monotherapy Data in Non-Small Cell Lung Cancer (NSCLC), Opening Second Stage of Monotherapy Trial and NSCLC Pembrolizumab Combination Cohort
November 02, 2022
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
VIB and Surface Oncology Announce Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388
October 19, 2022
From
Surface Oncology, Inc.
Via
GlobeNewswire
Tickers
SURF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.